Role of Implantable Intracardiac Defibrillators in Patients with Cardiac Immunoglobulin Light Chain Amyloidosis
Overview
Authors
Affiliations
Catheter Ablation in Arrhythmic Cardiac Diseases: Endocardial and Epicardial Ablation.
Cheng W, Chung F, Lin Y, Lo L, Chang S, Hu Y Rev Cardiovasc Med. 2024; 23(9):324.
PMID: 39077706 PMC: 11262352. DOI: 10.31083/j.rcm2309324.
Management of Arrhythmias and Conduction Disorders in Amyloid Cardiomyopathy.
Holcman K, Zabek A, Boczar K, Podolec P, Kostkiewicz M J Clin Med. 2024; 13(11).
PMID: 38892799 PMC: 11172576. DOI: 10.3390/jcm13113088.
Briasoulis A, Kourek C, Papamichail A, Loritis K, Bampatsias D, Repasos E J Cardiovasc Dev Dis. 2023; 10(8).
PMID: 37623350 PMC: 10455774. DOI: 10.3390/jcdd10080337.
Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis.
Fischer K, Lellouche N, Damy T, Martins R, Clementy N, Bisson A ESC Heart Fail. 2021; 9(1):740-750.
PMID: 34734471 PMC: 8787999. DOI: 10.1002/ehf2.13663.
Lizewska-Springer A, Slawinski G, Lewicka E J Clin Med. 2021; 10(9).
PMID: 33922892 PMC: 8123220. DOI: 10.3390/jcm10091858.